Treatment Indications: correction of moderate to deep wrinkles (including nasolabial folds, «marionette» lines, perioral lines);, restoration of soft tissue volume in the lower third of the face (cheeks, chin, scleral area);, contouring and harmonization of facial features (including lip augmentation for natural «plumpness», correction of lip asymmetry);, addressing skin laxity and mild ptosis in the lower face;, stimulation of collagen and elastin synthesis for improved skin quality
Release form: 2 × 1 mL pre-filled sterile glass syringes
Compound: cross-linked sodium hyaluronate (17.5 mg/mL) produced using VYCROSS technology (combines short and long polymer chains of hyaluronic acid)
Concentration of GC: 17.5 mg/mL
Lidocaine: 0.3%
Indications: volumizing and contouring in mid-to-deep dermal layers;, restoration of volume deficits and facial contour support;, smoothing moderate-to-deep depressions and folds;, providing balanced cohesion and plasticity with minimal migration (effect duration ~15–18 months)